Edgestream Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-8,449
| Closed | -$1.04M | – | 960 |
|
|
2025
Q4 | $1.04M | Buy |
8,449
+3,489
| +70% | +$424K | 0.03% | 689 |
|
|
2025
Q3 | $551K | Buy |
+4,960
| New | +$564K | 0.02% | 719 |
|
|
2025
Q2 | – | Sell |
-18,401
| Closed | -$2.06M | – | 922 |
|
|
2025
Q1 | $2.06M | Buy |
18,401
+9,152
| +99% | +$944K | 0.07% | 480 |
|
|
2024
Q4 | $854K | Sell |
9,249
-14,668
| -61% | -$1.32M | 0.04% | 598 |
|
|
2024
Q3 | $2.01M | Buy |
23,917
+11,618
| +94% | +$887K | 0.09% | 402 |
|
|
2024
Q2 | $844K | Sell |
12,299
-40,674
| -77% | -$2.71M | 0.04% | 560 |
|
|
2024
Q1 | $3.88M | Buy |
52,973
+43,300
| +448% | +$3.33M | 0.19% | 175 |
|
|
2023
Q4 | $784K | Sell |
9,673
-4,741
| -33% | -$369K | 0.06% | 493 |
|
|
2023
Q3 | $1.08M | Buy |
14,414
+11,472
| +390% | +$882K | 0.09% | 375 |
|
|
2023
Q2 | $227K | Sell |
2,942
-11,003
| -79% | -$878K | 0.02% | 673 |
|
|
2023
Q1 | $1.16M | Buy |
13,945
+6,337
| +83% | +$525K | 0.13% | 265 |
|
|
2022
Q4 | $653K | Sell |
7,608
-13,480
| -64% | -$1.07M | 0.07% | 321 |
|
|
2022
Q3 | $1.3M | Buy |
+21,088
| New | +$1.33M | 0.1% | 243 |
|
|
2022
Q1 | – | Sell |
-7,995
| Closed | -$581K | – | 575 |
|
|
2021
Q4 | $581K | Sell |
7,995
-1,695
| -17% | -$117K | 0.04% | 374 |
|
|
2021
Q3 | $677K | Buy |
+9,690
| New | +$681K | 0.04% | 361 |
|
|
2020
Q4 | – | Sell |
-82,753
| Closed | -$5.23M | – | 382 |
|
|
2020
Q3 | $5.23M | Buy |
+82,753
| New | +$5.74M | 0.34% | 97 |
|
|
2020
Q1 | – | Sell |
-17,595
| Closed | -$1.14M | – | 327 |
|
|
2019
Q4 | $1.14M | Buy |
17,595
+13,255
| +305% | +$863K | 0.06% | 221 |
|
|
2019
Q3 | $275K | Buy |
+4,340
| New | +$284K | 0.03% | 237 |
|
|
2019
Q2 | – | Sell |
-6,232
| Closed | -$405K | – | 250 |
|
|
2019
Q1 | $405K | Buy |
+6,232
| New | +$414K | 0.06% | 181 |
|
|
2016
Q4 | – | Sell |
-3,619
| Closed | -$286K | – | 107 |
|
|
2016
Q3 | $286K | Buy |
+3,619
| New | +$294K | 0.16% | 104 |
|
|
2016
Q2 | – | Sell |
-2,557
| Closed | -$235K | – | 58 |
|
|
2016
Q1 | $235K | Buy |
2,557
+54
| +2% | +$4.87K | 0.26% | 65 |
|
|
2015
Q4 | $253K | Sell |
2,503
-4,721
| -65% | -$491K | 0.72% | 52 |
|
|
2015
Q3 | $709K | Sell |
7,224
-50,581
| -88% | -$5.62M | 1.24% | 21 |
|
|
2015
Q2 | $6.77M | Buy |
57,805
+54,239
| +1,521% | +$5.93M | 4.67% | 3 |
|
|
2015
Q1 | $350K | Buy |
+3,566
| New | +$362K | 0.46% | 57 |
|
|
2014
Q4 | – | Sell |
-2,514
| Closed | -$268K | – | 67 |
|
|
2014
Q3 | $268K | Sell |
2,514
-732
| -23% | -$71.7K | 0.23% | 66 |
|
|
2014
Q2 | $269K | Sell |
3,246
-52,091
| -94% | -$4.05M | 0.17% | 71 |
|
|
2014
Q1 | $3.92M | Buy |
55,337
+49,565
| +859% | +$3.89M | 4.17% | 8 |
|
|
2013
Q4 | $433K | Buy |
+5,772
| New | +$402K | 0.93% | 24 |
|
Other funds holding GILD
Edgestream Partners's GILD Position: Q1 2026 in Review
Edgestream Partners sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 8,449 shares — an estimated $1.04M sold.
Edgestream Partners first reported a position in GILD in Q4 2013 and held it in 29 quarters. The position peaked at $6.77M in Q2 2015. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Edgestream Partners reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- Edgestream Partners sold 8,449 Gilead Sciences shares in Q1 2026, an estimated $1.04M.
- Edgestream Partners first reported a position in Gilead Sciences in Q4 2013 and held it in 29 quarters.
- Edgestream Partners's Gilead Sciences position peaked at $6.77M in Q2 2015.
- 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.